MKI67 and neoplasm: Ki-67 expression—typically quantified as the percentage of positively stained tumor nuclei—has been validated as an independent prognostic marker in GISTs: values exceeding thresholds such as 5%, 6%, or 8% consistently associate with higher recurrence risk and shorter recurrence-free survival, even within traditional high-risk groups [14].